▶ 調査レポート

神経モニタリングのヨーロッパ市場:成長・動向・市場規模予測(2020-2025)

• 英文タイトル:Europe Neurology Monitoring Market - Growth, Trends, and Forecasts (2020 - 2025)

Mordor Intelligenceが調査・発行した産業分析レポートです。神経モニタリングのヨーロッパ市場:成長・動向・市場規模予測(2020-2025) / Europe Neurology Monitoring Market - Growth, Trends, and Forecasts (2020 - 2025) / D0-MOR-AP1418資料のイメージです。• レポートコード:D0-MOR-AP1418
• 出版社/出版日:Mordor Intelligence / 2020年4月
• レポート形態:英文、PDF、80ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:健康管理
• 販売価格(消費税別)
  Single User¥555,000 (USD3,750)▷ お問い合わせ
  Team User¥629,000 (USD4,250)▷ お問い合わせ
  Corporate License¥1,036,000 (USD7,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、神経モニタリングのヨーロッパ市場について調査・分析した資料で、神経モニタリングの市場概要、動向、セグメント別市場規模、競争状況、企業情報、市場機会分析などで構成されています。

The key factors propelling the growth of the market the Europe are the increasing incidence of neurological disorders, huge investments by private players in neurology Monitoring Devices, increase in R&D in the field of neurotherapies, and rising aging population. The growth of the neurology Monitoring Devices market in Europe is also attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinson’s disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke.
The increasing healthcare spending, increasing investment by medical device manufactures, and increasing neurological disease prevalence are expected to drive the overall Neurology Monitoring Devices market growth in Europe.

Key Market Trends

Application in Parkinson’s Disease is expected to register a healthy CAGR

Parkinson’s disease is a progressive nervous system disorder that affects movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Wearable sensors are increasingly used to detect PD symptoms due to technological innovations, resulting in small, low cost, power-efficient, and accurate sensors. Wearable sensors have shown promise in detecting tremor, freezing of gait, bradykinesia, and dyskinesia.

The prevalence of Parkinson’s Disease has increased over the years in developed regions of Europe. This is primarily due to the rising geriatric population. Moreover, as per the 2017 “World Aging population” report by the United Nations, the population aged 60 years or above comprises 23.9% of the population in the United Kingdom and is expected to increase to 31.5% by 2050 as per the report estimates. As a result, the prevalence of Parkinson’s disease is also expected to increase in the future as well. This will increase the demand for Parkinson’s disease monitoring devices, which will help the market growth.

Competitive Landscape

The European market for neurology monitoring is moderately competitive and there are several international as well as local companies in the region. Due to the presence of almost all the global players in the neurology monitoring market, competition in the European market has become intense currently. Many of these global players have their headquarters in European countries, which increases the accessibility of neurology monitoring throughout Europe.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Incidence of Neurological Disorders
4.2.2 Growing Incidence of Traumatic Brain Injuries
4.2.3 Rise in the Aging Population
4.3 Market Restraints
4.3.1 High Cost of Equipment
4.3.2 Shortage of Trained Professionals
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Magnetic Resonance Imaging (MRI) Devices
5.1.2 Electroencephalography Devices
5.1.3 Cerebral Oximeters
5.1.4 Intracranial Pressure Monitors
5.1.5 Others
5.2 By Disease Type
5.2.1 Traumatic Brain Injury (TBI)
5.2.2 Stroke
5.2.3 Sleep Disorders
5.2.4 Parkinson’s Disease
5.2.5 Epilepsy
5.2.6 Other Diseases
5.3 Geography
5.3.1 Europe
5.3.1.1 Germany
5.3.1.2 United Kingdom
5.3.1.3 France
5.3.1.4 Italy
5.3.1.5 Spain
5.3.1.6 Rest of Europe

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Advanced Brain Monitoring Inc
6.1.2 Compumedics Limited
6.1.3 Dragerwerk Ag & Co Kgaa
6.1.4 GE Healthcare
6.1.5 Masimo Corporation
6.1.6 Medtronic Plc
6.1.7 Natus Medical Inc
6.1.8 Nihon Kohden Corporation
6.1.9 Philips Healthcare
6.1.10 Siemens Healthineers

7 MARKET OPPORTUNITIES AND FUTURE TRENDS